Home Cart Sign in  
Chemical Structure| 1448428-04-3 Chemical Structure| 1448428-04-3

Structure of Selonsertib
CAS No.: 1448428-04-3

Chemical Structure| 1448428-04-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Selonsertib (GS-4997), an orally bioavailable and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8.3, has been studied as a potential treatment for diabetic nephropathy and kidney fibrosis.

Synonyms: GS-4997; GS-4977

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Selonsertib

CAS No. :1448428-04-3
Formula : C24H24FN7O
M.W : 445.49
SMILES Code : O=C(C1=CC(N2C=C(N=C2)C3CC3)=C(C=C1F)C)NC4=NC(C5=NN=CN5C(C)C)=CC=C4
Synonyms :
GS-4997; GS-4977
MDL No. :MFCD29920355
InChI Key :YIDDLAAKOYYGJG-UHFFFAOYSA-N
Pubchem ID :71245288

Safety of Selonsertib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Selonsertib

MAPK

Isoform Comparison

Biological Activity

Target
  • ASK1

    ASK1, pIC50:8.3

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02509624 Diabetic Kidney Disease PHASE1 COMPLETED 2015-12-15 Denver, Colorado, United State... More >>s|Miami, Florida, United States|Orlando, Florida, United States|Minneapolis, Minnesota, United States|San Antonio, Texas, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.24mL

0.45mL

0.22mL

11.22mL

2.24mL

1.12mL

22.45mL

4.49mL

2.24mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories